发明名称 |
COMBINATION OF A PD-1 ANTAGONIST AND AN ALK INHIBITOR FOR TREATING CANCER |
摘要 |
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and an Anaplastic Lymphoma Kinase (ALK) inhibitor, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that test positive for ALK, PD-L 1, or both ALK and PD-L 1. |
申请公布号 |
WO2016032927(A1) |
申请公布日期 |
2016.03.03 |
申请号 |
WO2015US46477 |
申请日期 |
2015.08.24 |
申请人 |
PFIZER INC.;MERCK SHARP & DOHME CORP. |
发明人 |
DAS-YOUNG, LEENA;WILNER, KEITH, DAVID;HO, STEFFAN, NICHOLAS |
分类号 |
A61K31/4545;A61K39/395;A61P35/00 |
主分类号 |
A61K31/4545 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|